| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |